2018年12月25日，國(guo)家中醫藥管理局發布通知，全(quan)國(guo)99位中醫藥專家被評為(wei)中醫藥傳承與(yu)創新(xin)“百(bai)千萬”人才工(gong)程(cheng)（岐(qi)黃工(gong)程(cheng)）岐(qi)黃學者。

為推(tui)進中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)領(ling)軍(jun)人(ren)(ren)(ren)才隊(dui)伍建(jian)設，根據《中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)傳(chuan)承(cheng)(cheng)與創新“百千萬(wan)”人(ren)(ren)(ren)才工(gong)(gong)程(cheng)(cheng)（岐黃(huang)工(gong)(gong)程(cheng)(cheng)）實(shi)施方案》部(bu)署(shu)要求，國家(jia)(jia)中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)管理局組(zu)織實(shi)施國家(jia)(jia)中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)領(ling)軍(jun)人(ren)(ren)(ren)才支(zhi)(zhi)持計劃，并制定了《中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)傳(chuan)承(cheng)(cheng)與創新“百千萬(wan)”人(ren)(ren)(ren)才工(gong)(gong)程(cheng)(cheng)（岐黃(huang)工(gong)(gong)程(cheng)(cheng)）——國家(jia)(jia)中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)領(ling)軍(jun)人(ren)(ren)(ren)才支(zhi)(zhi)持計劃》，旨(zhi)在通(tong)過(guo)遴選百名岐黃(huang)學(xue)者和10名中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)首席科學(xue)家(jia)(jia)，充分發(fa)揮(hui)領(ling)軍(jun)人(ren)(ren)(ren)才的(de)引(yin)領(ling)帶動作用，逐步形成壯大支(zhi)(zhi)撐中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)事(shi)(shi)業(ye)傳(chuan)承(cheng)(cheng)發(fa)展的(de)高層次人(ren)(ren)(ren)才團隊(dui)，推(tui)動中(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)(yi)(yi)(yi)(yi)藥(yao)(yao)(yao)事(shi)(shi)業(ye)傳(chuan)承(cheng)(cheng)發(fa)展。

該計(ji)劃分階段進(jin)行，首先遴選(xuan)百名岐(qi)(qi)黃(huang)(huang)學者，再擇(ze)優遴選(xuan)10名中(zhong)(zhong)醫(yi)藥首席科(ke)學家。“岐(qi)(qi)黃(huang)(huang)學者”分臨床型(xing)和(he)科(ke)研(yan)型(xing)，遴選(xuan)在中(zhong)(zhong)醫(yi)藥臨床實踐或(huo)中(zhong)(zhong)醫(yi)藥基礎理論研(yan)究、應用(yong)研(yan)究中(zhong)(zhong)取(qu)得(de)重大成果，所從事的(de)工作取(qu)得(de)突出成績，在國內外具有較高(gao)學術(shu)影響力的(de)專業技術(shu)人(ren)員。計(ji)劃實施周期(qi)為(wei)期(qi)3年。中(zhong)(zhong)央(yang)財政為(wei)岐(qi)(qi)黃(huang)(huang)學者、中(zhong)(zhong)醫(yi)藥首席科(ke)學家分別安排人(ren)均不高(gao)于(yu)60萬元、100萬元的(de)經(jing)費支持，用(yong)于(yu)自主選(xuan)題研(yan)究、學習交(jiao)流、人(ren)才培養和(he)團隊建設等。

岐黃學者應結合所從事研究領(ling)域，圍繞中醫(yi)藥發展需求和重點問題，開(kai)展創新性、探索性和應用性研究，加強團(tuan)隊(dui)建設，積極(ji)推動解(jie)決(jue)中醫(yi)藥領(ling)域發展中面臨的臨床或科研難題，形成(cheng)行業(ye)內外有較大影響力的標(biao)志性成(cheng)果，中醫(yi)藥研究和服(fu)務能力明顯提升，成(cheng)為中醫(yi)藥領(ling)軍人(ren)才(cai)。